Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.59	19.19	15.11	11.78	42.35	21.35
Cash & Short-Term Investments	17.59	19.19	15.11	11.78	42.35	21.35
Cash Growth	95.45%	27.01%	28.26%	-72.18%	98.34%	-51.37%
Other Receivables	1.67	2.35	1.03	2.4	0	1
Receivables	1.67	2.35	1.03	2.4	0	1
Prepaid Expenses	1.13	0.48	0.99	1.85	2.48	2.06
Restricted Cash	1.35	-	-	-	1.15	-
Other Current Assets	-	-	-	0.59	-	-
Total Current Assets	21.73	22.02	17.13	16.62	45.98	24.41
Property, Plant & Equipment	-	-	-	-	22.15	21.2
Other Long-Term Assets	-	-	-	17.8	-	-
Total Assets	21.73	22.02	17.13	34.42	68.14	45.61
Accounts Payable	1.66	1.07	0.96	1.1	5.14	2.94
Accrued Expenses	0.33	2.19	1.91	1.27	3.33	2.95
Current Portion of Leases	-	-	-	-	0.62	0.39
Current Unearned Revenue	1.35	-	-	-	1.15	-
Other Current Liabilities	-	0.2	0.21	5.41	2.66	0.13
Total Current Liabilities	3.35	3.46	3.07	7.78	12.9	6.4
Long-Term Leases	-	-	-	-	11.25	11.87
Other Long-Term Liabilities	-	-	-	7.04	-	-
Total Liabilities	3.35	3.46	3.07	14.82	24.15	18.27
Common Stock	0.02	0.01	0.01	0.01	0.01	0.05
Additional Paid-In Capital	475.85	465.56	450.33	447.64	442.1	383.53
Retained Earnings	-457.48	-447.02	-436.29	-428.05	-398.12	-356.24
Shareholders' Equity	18.39	18.56	14.05	19.6	43.99	27.34
Total Liabilities & Equity	21.73	22.02	17.13	34.42	68.14	45.61
Total Debt	-	-	-	-	11.87	12.26
Net Cash (Debt)	17.59	19.19	15.11	11.78	30.48	9.1
Net Cash Growth	95.45%	27.01%	28.26%	-61.35%	235.15%	-79.05%
Net Cash Per Share	1.38	2.14	1.72	1.41	3.98	1.93
Filing Date Shares Outstanding	16.67	10.71	8.9	8.8	8.31	5.07
Total Common Shares Outstanding	16.7	10.71	8.89	8.41	8.31	5.07
Working Capital	18.39	18.56	14.05	8.84	33.08	18.01
Book Value Per Share	1.10	1.73	1.58	2.33	5.29	5.39
Tangible Book Value	18.39	18.56	14.05	19.6	43.99	27.34
Tangible Book Value Per Share	1.10	1.73	1.58	2.33	5.29	5.39
Machinery	-	-	-	-	9.66	3.87
Construction In Progress	-	-	-	-	2.23	6.79
Leasehold Improvements	-	-	-	-	3.17	0.29

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q